soja

Condiciones de salud que soja puede ayudar a apoyar.

• HipocondríaCientífico

  Soy isoflavones, particularly genistein, daidzein, and the equol metabolite, possess antioxidant activity. The Linus Pauling Institute notes isoflavones can act as antioxidants in vitro, while the extent of contribution to antioxidant status in humans remains incompletely characterized. Equol has been identified as the most potent antioxidant among soy isoflavones and their metabolites. Soy intake is also associated with improvements in antioxidant status in chronic kidney disease patients.

• Síndrome de Inmunodeficiencia AdquiridaCientífico

  Soy isoflavones have been studied for effects on arterial function, including endothelial function, arterial stiffness, and atherosclerosis progression. Isoflavones interact with estrogen receptors in endothelial cells, enhancing nitric oxide production and promoting vasodilation. Epidemiological data link high soy intake in Asian populations with lower cardiovascular disease prevalence, and clinical studies show improvements in vascular biomarkers, particularly in equol-producing individuals.

• HipotensiónCientífico

  A meta-analysis of 11 randomized controlled trials found soy isoflavones significantly reduced systolic and diastolic blood pressure in hypertensive subjects, but not in normotensive individuals. Several meta-analyses of epidemiological and clinical trials have shown dietary soy isoflavones lower blood pressure sufficiently in hypertensive and pre-hypertensive subjects to reduce overall cardiovascular risk. Isoflavones appear to act through enhancement of endothelial nitric oxide synthase activity, improving vasodilation.

• Fatiga SuprarrenalCientífico

  Soy protein and isoflavones have been studied for effects on fasting glucose and insulin in individuals with type 2 diabetes and metabolic syndrome. A meta-analysis of 11 studies found soy protein could lower fasting glucose, insulin, and HOMA-IR in patients with type 2 diabetes and metabolic syndrome, though results are inconsistent across studies. Benefits appear most consistent in individuals with elevated baseline glucose or metabolic dysfunction.

• Manchas de la edadCientífico

  Multiple meta-analyses of randomized controlled trials support that soy isoflavones improve bone mineral density (BMD), particularly lumbar spine BMD, in postmenopausal women. A 2019 PubMed meta-analysis of 52 trials found significant BMD improvements at the lumbar spine, hip, and femoral neck with soy isoflavone consumption. Results are most consistent for lumbar spine, with effects at hip sites less uniform. Doses above approximately 75–80 mg/day isoflavones appear most effective.

• Válvula IleocecalCientífico

  Soy protein has well-documented LDL-cholesterol-lowering effects, leading to FDA and Health Canada regulatory approval of a cardiovascular health claim. A meta-analysis of 46 trials confirmed soy protein significantly reduces LDL and total cholesterol in adults. The average effect across randomized trials is modest (approximately 3–5% reduction in LDL), with larger effects in hypercholesterolemic individuals. Soy isoflavones alone show minimal independent lipid-lowering effect.

• ApendicitisCientífico

  Soy isoflavones have demonstrated anti-inflammatory activity in clinical studies, with meta-analyses showing reductions in the inflammatory marker CRP in postmenopausal women. Genistein inhibits tyrosine kinase signaling involved in pro-inflammatory pathways. Animal and clinical studies show soy isoflavones can down-regulate TNF-α and other pro-inflammatory mediators.

• IncontinenciaCientífico

  Soy isoflavones are investigated for potential protection against age-related cognitive decline and dementia via estrogenic and antioxidant mechanisms in the brain. Epidemiological studies in East Asian populations with high soy consumption show inverse associations between isoflavone intake and cognitive decline. RCTs in Western populations have not consistently replicated cognitive benefits, with the discrepancy attributed to gut microbiota-dependent equol production differences between populations.

• Vejiga (irritable)Científico

  Soy isoflavones are phytoestrogens that interact with estrogen receptors alpha and beta, acting as selective estrogen receptor modulators with tissue-specific agonist or antagonist activity. When endogenous estrogen is low (e.g., postmenopause), they can exert mild estrogenic agonism; when estrogen is high (e.g., premenopause), they may compete as partial antagonists. By inhibiting aromatase and modulating sex hormone-binding globulin, soy isoflavones can also alter the metabolism and bioavailability of endogenous estrogens.

• Leche materna (secar)Científico

  The gut microbiome extensively modulates soy isoflavone bioactivity, converting daidzein to the more potent equol, which in turn alters cardiovascular, hormonal, and metabolic outcomes. Soy food intake has been associated with changes in gut metabolome and microbiome composition. Soy's dietary fiber content acts as a prebiotic substrate, and the relationship between soy and gut microbiota is bidirectional.

• BronquitisCientífico

  Soy isoflavones and soy protein are associated with multiple physiological factors relevant to healthy aging, including preservation of bone density, cardiovascular risk reduction, maintenance of muscle-supportive protein intake, and potential neuroprotective effects. The broad cardiometabolic, anti-inflammatory, and antioxidant properties of soy foods collectively support healthy aging, particularly in postmenopausal women.

• Moretones (prevención)Científico

  Clinical evidence suggests soy isoflavones may modestly reduce waist and hip circumference, particularly in overweight and metabolically compromised individuals. An RCT found waist circumference decreased significantly in soy isoflavone recipients, and soy protein has anti-obesogenic properties attributed partly to isoflavone activity. Soy isoflavones are noted to have anti-obesogenic properties in a PMC review on cardiovascular health.

• JuanetesCientífico

  Soy foods and protein have been associated with cardiovascular benefit, leading to a 1999 FDA health claim linking ≥25 g/day soy protein with reduced coronary heart disease risk. The overall direct benefit of soy protein or isoflavone supplements on cardiovascular outcomes is now considered modest, but soy foods' favorable macronutrient profile (high polyunsaturated fat, fiber, low saturated fat) supports cardiovascular health. Soy isoflavones may benefit heart health through multiple mechanisms beyond cholesterol-lowering including anti-inflammatory and antioxidant pathways.

• Cáncer (prevención)Científico

  A systematic review and meta-analysis of 17–19 RCTs found soy isoflavones significantly reduced hot flash frequency by approximately 20% and severity by approximately 26% compared with placebo. Asian postmenopausal women, who consume substantially more dietary soy, have a markedly lower incidence of hot flashes than Western women. Evidence is clinically meaningful but effect sizes are moderate and heterogeneity across trials is high.

• Olor de piesCientífico

  Clinical evidence, while mixed, suggests that soy protein and isoflavones can improve insulin sensitivity, particularly in postmenopausal women and those with metabolic syndrome. Soy isoflavones at doses ≥90 mg/day have been shown to reduce insulin levels in healthy postmenopausal women. The mechanism may involve PPAR pathway activation and improved lipid metabolism, with variability linked to individual equol-production status.

• Daño del CartílagoCientífico

  Clinical and mechanistic evidence supports that soy protein has renoprotective effects, particularly in chronic kidney disease (CKD). Soy protein has been shown to have direct renal effects that improve renal function, and soy intake is associated with improvements in antioxidant status and reduced systemic inflammation in CKD patients. Genistein prevents CKD development by inhibiting inflammation and fibrosis. Soy protein may lower blood pressure through decreased angiotensin-converting enzyme activity, indirectly protecting the kidneys.

• EscalofríosCientífico

  Soy isoflavones have been studied for effects on memory and cognitive function via interaction with estrogen receptors in the brain and antioxidant mechanisms. Observational studies and randomized controlled trials in humans have yielded inconclusive results, with approximately 50% of studies showing positive effects and the other half showing null or negative findings. Neuroprotective effects of isoflavones have been demonstrated in animal studies.

• CóleraCientífico

  Soy isoflavones have been extensively studied as an alternative to menopausal hormone therapy for vasomotor and other menopausal symptoms. Clinical evidence supports modest reductions in hot flash frequency and severity; effects on other menopausal symptoms such as depression, bone loss, and vaginal dryness have also been studied. Meta-analytic evidence supports isoflavones as effective in improving BMD and reducing hot flashes in postmenopausal women.

• GingivitisCientífico

  Several randomized clinical trials have assessed soy's effects on multiple components of metabolic syndrome, finding improvements in lipid profiles, insulin levels, waist circumference, and blood pressure. A PMC review (2021) specifically examined soy isoflavones for metabolic syndrome prevention, finding evidence for lipid profile improvement and oxidative stress reduction. Effects are most consistent for lipid parameters, with glucose effects being less reliable.

• Infección (bacteriana)Científico

  Soy isoflavones have been evaluated in multiple RCTs and meta-analyses for osteoporosis prevention, primarily in postmenopausal women. Evidence supports modest improvements in lumbar spine BMD and reduction in bone resorption markers. Results at hip sites are less consistent. Clinical data suggest approximately 80 mg/day isoflavones are needed to derive skeletal benefits.

• Congestión (bronquial)Científico

  Soy isoflavones have been studied in perimenopausal women for relief of vasomotor and other transitional symptoms, with a 2025 PMC systematic review and meta-analysis specifically evaluating their effects in this population. Effects on hot flashes and depression symptoms have been documented in perimenopausal women. The phytoestrogenic activity of soy isoflavones is considered especially relevant during the perimenopausal transition when endogenous estrogen is fluctuating.

• Toxicidad por CobreCientífico

  Epidemiological evidence associates higher soy food consumption with reduced prostate cancer risk in men. A meta-analysis of 30 studies (266,699 participants) demonstrated that total soy consumption is associated with a reduction in prostate cancer risk. However, clinical trial evidence on PSA levels is inconsistent, with most RCTs finding soy or isoflavone supplementation does not significantly affect PSA. Soy isoflavones may modulate androgen receptor activity.

• DebilidadCientífico

  Clinical evidence indicates soy protein can reduce triglyceride levels, particularly in individuals with hypertriglyceridemia. A review of clinical studies found that soy-protein diets decrease triglycerides, especially in subjects with elevated baseline levels, though effects on HDL are minimal. One controlled trial in hyperlipidemic subjects found soy protein reduced triglycerides by 12.4%. Evidence for soy isoflavones alone on triglycerides is less consistent.

Sistemas corporales que soja puede ayudar a apoyar.

• No hay sistemas corporales disponibles.